4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Arrhythmias coexist in patients with heart failure (HF) and left ventricular (LV) dysfunction.
Tachycardias, atrial fibrillation, and premature ventricular contractions are known to trigger a …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

PVCs and Left Ventricular Dysfunction. Background: Frequent premature ventricular
complexes (PVCs) can cause a decline in left ventricular ejection fraction (LVEF). We …

Background—The purpose of this study was to compare the efficacy of radiofrequency
catheter ablation (RFCA) versus antiarrhythmic drugs (AADs) for treatment of patients with …

Background It is unknown whether radiofrequency ablation (RFA) or antiarrhythmic therapy
is superior when treating patients with symptomatic premature ventricular contractions …

They are often seen in association with structural heart disease and represent increased risk
of sudden death, 1 yet they are ubiquitous, even in the absence of identifiable heart disease …

Tachycardia mediated cardiomyopathy (TMC) is a reversible form of dilated cardiomyopathy
that can occur with most supraventricular and ventricular arrhythmias. Despite the plethora …

Background: The pathophysiology of cardiomyopathy associated with premature ventricular
contractions (PVCs) remains unclear. Objectives: This study prospectively explored …